A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
Clinical trial NCT02087423 · COMPLETED
Trial details
- NCT number
- NCT02087423
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-25
- Primary completion
- 2016-06-03
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.